$58.11
+0.95 (+1.66%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+63.37%
YTD
+98.46%
Open$57.41
Previous Close$57.16
Day High$58.62
Day Low$56.56
52W High$59.30
52W Low$26.76
Volume—
Avg Volume1.47M
Market Cap8.81B
P/E Ratio19.95
EPS$2.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$30.02
Above
SMA 200
$32.89
Above
RSI (14)
46.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+7.4% upside
Current
$58.11
$58.11
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 591.27M | 1.04B | 1.08B |
| Net Income | 429.02M | 129.57M | 136.18M |
| Profit Margin | 72.6% | 12.5% | 12.7% |
| EBITDA | 118.37M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +504.9% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |